ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grootendorst, D.
Right arrow Articles by Roldaan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grootendorst, D.
Right arrow Articles by Roldaan, A.
Eur Respir J 1999; 13: 647-653
Copyright © ERS Journals Ltd 1999

Clinical Trial

Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity

DC Grootendorst, JW van den Bos, JJ Romeijn, M Veselic-Charvat, EJ Duiverman, EJ Vrijlandt, PJ Sterk, and AC Roldaan

This study examined the safety of sputum induction and the relation between sputum cell counts and clinical parameters in adolescents with severe persistent asthma. Within 5 days, induced sputum and reversibility in forced expiratory volume in one second (FEV1), quality of life, provocative concentration causing a 20% fall in FEV1 (PC20) of adenosine monophosphate and histamine, exercise-induced bronchoconstriction, overall asthma severity index, and blood eosinophils were collected in 20 atopic adolescents with moderate-to-severe persistent asthma (12-18 yrs of age, FEV1 65-110% of predicted, on 500-2,000 microg inhaled steroids daily). FEV1 was reversible by 13.3-2.3% pred. After sputum induction, FEV1 was still increased by 9.0+/-2.6% pred as compared to the pre-salbutamol baseline. Sputum contained, median (range): 12.4 (0.4-59.5)% squamous cells, 47.3 (6.8-84.0)% macrophages, 39.0 (4.6-84.8)% neutrophils, 4.8 (1.0-12.4)% lymphocytes, 0.4 (0-10.8)% eosinophils and 3.6 (0-23.4)% bronchial epithelial cells. Sputum eosinophils showed a trend towards a significant association with the overall asthma severity index (r=0.46, p=0.06) and correlated inversely with baseline FEV1 (r=-0.51, p=0.03). In conclusion, sputum can be induced safely in adolescents with moderate-to-severe persistent asthma, if pretreated with beta2-agonists. Despite relatively low sputum eosinophil counts in these patients on inhaled steroids, the association of eosinophil numbers with baseline forced expiratory volume in one second and asthma severity index favours a role of induced sputum in monitoring adolescents with severe asthma.


This article has been cited by other articles:


Home page
 ThoraxHome page
D. C Grootendorst, S. A Gauw, R. M Verhoosel, P. J Sterk, J. J Hospers, D. Bredenbroker, T. D Bethke, P. S Hiemstra, and K. F Rabe
Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD
Thorax, December 1, 2007; 62(12): 1081 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P G Gibson, J L Simpson, R Hankin, H Powell, and R L Henry
Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma
Thorax, February 1, 2003; 58(2): 116 - 121.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Romagnoli, I. Vachier, P. Tarodo de la Fuente, H. Meziane, C. Chavis, J. Bousquet, P. Godard, and P. Chanez
Eosinophilic inflammation in sputum of poorly controlled asthmatics
Eur. Respir. J., December 1, 2002; 20(6): 1370 - 1377.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Leader of the Working Group: E. Pizzichini, Members of the Working Group:, M.M.M. Pizzichini, R. Leigh, R. Djukanovic, and P.J. Sterk
Safety of sputum induction
Eur. Respir. J., July 1, 2002; 20(37_suppl): 9S - 18s.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
Leader of the Working Group:, P.G. Gibson, Members of the Working Group:, D.C. Grootendorst, R. Henry, I. Pin, P.L. Rytila, P. Wark, N. Wilson, and R. Djukanovic
Sputum induction in children
Eur. Respir. J., July 1, 2002; 20(37_suppl): 44S - 46s.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. ten BRINKE, C. de LANGE, A. H. ZWINDERMAN, K. F. RABE, P. J. STERK, and E. H. BEL
Sputum Induction in Severe Asthma by a Standardized Protocol . Predictors of Excessive Bronchoconstriction
Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 749 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. V. FAHY, H. A. BOUSHEY, S. C. LAZARUS, E. A. MAUGER, R. M. CHERNIACK, V. M. CHINCHILLI, T. J. CRAIG, J. M. DRAZEN, J. G. FORD, J. E. FISH, et al.
Safety and Reproducibility of Sputum Induction in Asthmatic Subjects in a Multicenter Study
Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1470 - 1475.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. E. Alexis, J. Soukup, S. Nierkens, and S. Becker
Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma
Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L369 - L375.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
N. M Wilson, P. Bridge, A. Spanevello, and M. Silverman
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity
Thorax, September 1, 2000; 55(9): 768 - 774.
[Abstract] [Full Text]

Home page
 ThoraxHome page
E. Rosi and G. Scano
Association of sputum parameters with clinical and functional measurements in asthma
Thorax, March 1, 2000; 55(3): 235 - 238.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.